January 13, 2014
Mary Lynn McPherson, PharmD, discusses the appeal of hydrocodone combination products to drug abusers.
January 9, 2014
Jeff Fudin, PharmD, FCCP, argues that there is no evidence to support categorizing hydrocodone combination products as Schedule II drugs rather than Schedule III drugs.
January 8, 2014
In the first in a series of videos on regulation of hydrocodone combination products, Mary Lynn McPherson, PharmD, discusses the dramatic increase in the use of opioids in the United States.
January 7, 2014
Fourth-generation pharmacist Joe Moose, PharmD, reflects on how pharmacy practice has changed and remained the same over the years.
December 18, 2013
Robert Granko, PharmD, MBA, explains how data analytics can help health-system pharmacies help plan their business more strategically.
December 16, 2013
Stephen F. Eckel, PharmD, MHA, discusses how the ongoing implementation of the Affordable Care Act will affect health systems generally and health-system pharmacists in particular.
December 12, 2013
Jonathan G. Marquess, PharmD, CDE, explains why going out of your way to serve diabetes patients can help grow your pharmacy’s business.
December 4, 2013
Joe Moose, PharmD, discusses the importance of working with physicians and other health care providers to serve patients’ needs.
December 2, 2013
Stephan Foster, PharmD, FAPha, discusses which vaccines pharmacists should be providing in addition to the seasonal influenza vaccine.
November 27, 2013
Robert Granko, PharmD, MBA, discusses the importance of building trust among those who will use data analytics and be affected by its use in health-system pharmacy.